Bionano Senior Management Team Member, President and CEO Erik Holmlin, PhD
Erik Holmlin, PhD
President and Chief Executive Officer

Erik Holmlin is a dynamic leader with more than two decades of experience developing innovative solutions and companies in the life sciences and health care industries.

Read More

Erik’s experience includes positions at GenVault Corporation (CEO), Exiqon A/S (CCO) and Becton Dickinson (vice president of marketing and development). In 2001, Erik led the formation and financing efforts of GeneOhm Sciences, Inc. and orchestrated the company’s acquisition by Becton Dickinson in 2006. He also served as an entrepreneur in residence (EIR) at leading life-science venture capital firm Domain Associates, LLC.

Erik was a National Institutes of Health postdoctoral fellow at Harvard University and a National Science Foundation predoctoral fellow at the California Institute of Technology, Pasadena (Caltech). He holds a PhD in chemistry from Caltech and MBAs from UC Berkeley and Columbia University.

Read Less
Bionano Senior Management Team Member, VP, Corporate Development, Mike Ward
Mike Ward
Chief Financial Officer

Mike Ward has more than 20 years of experience in life sciences-dedicated investment banking, venture capital and private equity investments.

Read More

Before joining Bionano Genomics, Mike was at Lurie Investment Fund, where he was responsible for managing the life sciences venture capital and private equity investments of the Lurie family. Mike guided senior management teams of Lurie’s life sciences portfolio companies in conducting business and corporate development, clinical and regulatory strategy, commercialization planning, intellectual property management, M&A, and financings. During his tenure, Mike also served on the boards of a number of life sciences portfolio companies on behalf of Lurie.

Prior to joining Lurie Investment Fund, Mike gained more than 15 years of investment banking experience at Leerink Partners, Credit Suisse, Dresdner Kleinwort Wasserstein, BMO and Vector Securities. During his career in investment banking, Mike executed more than 80 life sciences mergers, acquisitions, divestitures, strategic alliances, private placements, IPOs and follow-on public offerings. In his more than two decades of experience serving and fostering life sciences companies, Mike has focused predominantly on the medical technology, tools, diagnostics and biopharmaceutical markets. Mike received, with summa cum laude distinction, a bachelor’s in finance from the University of Illinois.

Read Less
Bionano Senior Management Team Member, VP, Systems Development, Mark Borodkin
Mark Olkdakowski
Chief Operating Officer

Mark Olkdakowski has a 20-year history of success in the development of systems for the life sciences and medical device industries.

Read More

Prior to joining Bionano Genomics, Mark led a global team at Brooks Life Science Systems in the development of sample analyzers, high-throughput screening solutions, and chemical storage and biobank systems. Prior to his time at Brooks, Mark was with Affymetrix, where he launched the array platform that is widely used today for GWAS and other genomics applications. Mark also spent time at Siemens Healthcare Diagnostics on the development of equipment for diagnostic core labs. During his 13 years at Life Technologies (formerly Applied Biosystems) he held various levels of responsibility in the development of systems for real-time PCR, sequencing and sample preparation. Mark holds a bachelor’s degree in electrical engineering and a master’s degree in computer and systems engineering from Rensselaer Polytechnic Institute in New York.

Read Less
Warren Robinson
Chief Commercial Officer

Warren Robinson has served as Bionano Genomics’ Chief Commercial Officer since November 2017 and previously served as a Vice President with Bionano in various sales and marketing functions from October 2015 to November 2017, including most recently as our Vice President of Global Sales and Marketing.

Read More

From June 2013 to October 2015, Mr. Robinson served as Division Vice President of Aegis Chemical Solutions, LLC, a private oil production services company. Previously, Mr. Robinson held various leadership roles in sales-focused positions with Life Technologies Corporation, a publicly traded research tool’s company acquired by Thermo Fisher Scientific Inc. in February 2014, and Invitrogen Corporation, a public research tools company acquired by Life Technologies in January 2008. Mr. Robinson received his bachelor’s degree in biochemistry from The University of Lethbridge, a research university located in Canada.

Read Less

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.